Xi Jinping seems to believe that only his continued rule can secure China’s rise. But as he ages, choosing a successor will ...
Over the decades, China's five-year plans have guided continuous progress in national development and living standards, from ...
One of China’s most important meetings begins Monday, as its top leader Xi Jinping and other ruling Communist Party elites ...
China’s Communist Party is set to hold its Fourth Plenary Session from October 20-23, 2025 — a confidential political ...
NCAP, or the New Car Assessment Program, is a globally recognized auto safety evaluation system with 11 regional institutions ...
5hon MSN
Roiled by purges and buffeted by US frictions, China’s leadership meets to chart country’s rise
Chinese leader Xi Jinping is convening a key political meeting this week where he will push forward his next five-year ...
The president and top White House officials have floated using tariff revenue to pay the military and support farmers. It's ...
At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing ...
Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback